Intercept Shares Turn Negative Following Mid-Day Sell Rating From Cantor

By: via Benzinga
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) shares took an intra-day turn lower Wednesday after Cantor Fitzgerald issued a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.